Terms: = Pancreatic cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169
116 results:
1. ezh2 as a potential therapeutic target for gastrointestinal cancers.
Hashemi M; Nazdari N; Gholamiyan G; Paskeh MDA; Jafari AM; Nemati F; Khodaei E; Abyari G; Behdadfar N; Raei B; Raesi R; Nabavi N; Hu P; Rashidi M; Taheriazam A; Entezari M
Pathol Res Pract; 2024 Jan; 253():154988. PubMed ID: 38118215
[TBL] [Abstract] [Full Text] [Related]
2. Targeting polycomb repressor complex 2-mediated bivalent promoter epigenetic silencing of secreted frizzled-related protein 1 inhibits cholangiocarcinoma progression.
Wu G; Wang Q; Wang D; Xiong F; Liu W; Chen J; Wang B; Huang W; Wang X; Chen Y
Clin Transl Med; 2023 Dec; 13(12):e1502. PubMed ID: 38050190
[TBL] [Abstract] [Full Text] [Related]
3. β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy.
Nakagawa C; Kadlera Nagaraj M; Hernandez JC; Uthay Kumar DB; Shukla V; Machida R; Schüttrumpf J; Sher L; Farci P; Mishra L; Tahara SM; Ou JJ; Machida K
Front Immunol; 2023; 14():1204907. PubMed ID: 37744383
[TBL] [Abstract] [Full Text] [Related]
4. Analysis on ezh2: mechanism identification of related CeRNA and its immunoassay in hepatocellular carcinoma.
Zhao H; Liu H; Kang W; Zhan C; Man Y; Qu T
BMC Med Genomics; 2023 Aug; 16(1):201. PubMed ID: 37626362
[TBL] [Abstract] [Full Text] [Related]
5. Long non-coding RNA SNHG17 contributes to the progression of pancreatic adenocarcinoma by modulating miR-32-5p/ezh2/STAT3 signaling.
Ying L; Wang J; Feng J; Wu Z
Mol Biol Rep; 2023 Jul; 50(7):5941-5947. PubMed ID: 37253918
[TBL] [Abstract] [Full Text] [Related]
6. ezh2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4.
Li H; Wang H; Cui Y; Jiang W; Zhan H; Feng L; Gao M; Zhao K; Zhang L; Xie X; Zhao N; Li Y; Liu P
Hereditas; 2023 May; 160(1):23. PubMed ID: 37198697
[TBL] [Abstract] [Full Text] [Related]
7. Multi-regulator of ezh2-PPARs Therapeutic Targets: A Hallmark for Prospective Restoration of pancreatic Insulin Production and cancer Dysregulation.
Olowosoke CB; Gbemisola O; Alaba AA; Adepoju OH; Okorie B; Odjegba PI; Ogunsanmi AO; Oke GA; Akinlolu O; Olubena TL; Bello RO; Adegboyega BB
Appl Biochem Biotechnol; 2023 Dec; 195(12):7520-7552. PubMed ID: 37010741
[TBL] [Abstract] [Full Text] [Related]
8. Design, Synthesis, and Biological Evaluation of a Potent Dual ezh2-BRD4 Inhibitor for the Treatment of Some Solid Tumors.
Huang N; Liao P; Zuo Y; Zhang L; Jiang R
J Med Chem; 2023 Feb; 66(4):2646-2662. PubMed ID: 36774555
[TBL] [Abstract] [Full Text] [Related]
9. Determination of ERG(+), ezh2, NKX3.1, and SPINK-1 subtypes to evaluate their association with clonal origin and disease progression in multifocal prostate cancer.
Segura-Moreno YY; Sanabria-Salas MC; Mesa-López De Mesa JA; Varela-Ramirez R; Acosta-Vega NL; Serrano ML
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1728. PubMed ID: 36199157
[TBL] [Abstract] [Full Text] [Related]
10. Long non-coding RNA SNHG16 decreased SMAD4 to induce gemcitabine resistance in pancreatic cancer via ezh2-mediated epigenetic modification.
Yu Y; Zou YF; Hong RQ; Chen WJ; Chen L; Chen WQ; Wang HP; Yu Y
Kaohsiung J Med Sci; 2022 Oct; 38(10):981-991. PubMed ID: 36053032
[TBL] [Abstract] [Full Text] [Related]
11. TGF-β1/Smad3 upregulates UCA1 to promote liver fibrosis through DKK1 and miR18a.
Yang Z; Zhang H; Yin M; Cheng Z; Jiang P; Feng M; Liu Z; Liao B
J Mol Med (Berl); 2022 Oct; 100(10):1465-1478. PubMed ID: 36001113
[TBL] [Abstract] [Full Text] [Related]
12. Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expression of Cyclin D1 and WEE1, phosphorylates TP53 and reduces cell proliferation in a kinase-dependent manner.
Woods ML; Weiss A; Sokol AM; Graumann J; Boettger T; Richter AM; Schermuly RT; Dammann RH
Cancer Gene Ther; 2022 Dec; 29(12):1975-1987. PubMed ID: 35902728
[TBL] [Abstract] [Full Text] [Related]
13. miR-137 Modulates Human Gastric cancer Cell Proliferation, Apoptosis, and Migration by Targeting ezh2.
Weng XQ; Wang W
Crit Rev Eukaryot Gene Expr; 2022; 32(4):31-40. PubMed ID: 35695663
[TBL] [Abstract] [Full Text] [Related]
14. SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine.
Wang ZW; Pan JJ; Hu JF; Zhang JQ; Huang L; Huang Y; Liao CY; Yang C; Chen ZW; Wang YD; Shen BY; Tian YF; Chen S
Cell Rep; 2022 May; 39(6):110813. PubMed ID: 35545048
[TBL] [Abstract] [Full Text] [Related]
15. Design and Synthesis of Dual ezh2/BRD4 Inhibitors to Target Solid Tumors.
Guo Z; Sun Y; Liang L; Lu W; Luo B; Wu Z; Huo B; Hu Y; Huang P; Wu Q; Wen S
J Med Chem; 2022 May; 65(9):6573-6592. PubMed ID: 35500243
[TBL] [Abstract] [Full Text] [Related]
16. The role of HMGA1 protein in gastroenteropancreatic neuroendocrine tumors.
De Martino M; Pellecchia S; Esposito F; Tosti N; Quintavalle C; Eppenberger-Castori S; Carafa V; Righi A; Chieffi P; Fusco A; Terracciano LM; Pallante P
Cell Cycle; 2022 Jun; 21(12):1335-1346. PubMed ID: 35282770
[TBL] [Abstract] [Full Text] [Related]
17. ezh2 suppresses insulinoma development by epigenetically reducing KIF4A expression via H3K27me3 modification.
Zhang S; Liu J; Li F; Yang M; Wang J
Gene; 2022 May; 822():146317. PubMed ID: 35182680
[TBL] [Abstract] [Full Text] [Related]
18. SOX8 Affects Tumoral SPARC Expression by Regulating ezh2 to Attenuate Effectiveness of albumin-bound paclitaxel in PDAC.
Yuan S; Xu J; Zhou B; Zhou Y; Lang M; Cao J; Liu Z; Yang S; Gao S; Hao J
Int J Biol Sci; 2022; 18(3):911-922. PubMed ID: 35173526
[TBL] [Abstract] [Full Text] [Related]
19. Preferential Mobilization of Colonic Hepatic Flexure Facilitates pancreaticoduodenectomy Procedures.
Liang H; Cheng L; Yan H; Cui J
Surg Laparosc Endosc Percutan Tech; 2021 Dec; 32(2):223-227. PubMed ID: 34966152
[TBL] [Abstract] [Full Text] [Related]
20. Chromatin-Independent Interplay of NFATc1 and ezh2 in pancreatic cancer.
Patil S; Forster T; Reutlinger K; Kopp W; Versemann L; Spitalieri J; Gaedcke J; Ströbel P; Singh SK; Ellenrieder V; Neesse A; Hessmann E
Cells; 2021 Dec; 10(12):. PubMed ID: 34943970
[TBL] [Abstract] [Full Text] [Related]
[Next]
